Home  >  Products  >  KMO (kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) ) Blocking Peptide (the N terminal of KMO)(100ug)
KMO (kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) ) Blocking Peptide (the N terminal of KMO)(100ug)

KMO (kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) ) Blocking Peptide (the N terminal of KMO)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KMO Antibody (ARP64018_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64018
Size: 100ug
Weight: 56kDa
Gene: 8564
Format: Lyophilized powder
Target: This gene encodes a mitochondrion outer membrane protein that catalyzes the hydroxylation of L-tryptophan metabolite, L-kynurenine, to form L-3-hydroxykynurenine. Studies in yeast identified this gene as a therapeutic target for Huntington disease.
Alternative names: dJ317G22.1
See Full Product Listings >